Table of Contents Asia-Pacific Cancer Supportive Care Medicine Market Report 2012-2023 1 Cancer Supportive Care Medicine Overview 1.1 Product Overview and Scope of Cancer Supportive Care Medicine 1.2 Classification of Cancer Supportive Care Medicine by Product Category 1.2.1 Asia-Pacific Cancer Supportive Care Medicine Sales (K Units) Comparison by Types (2012-2023) 1.2.2 Asia-Pacific Cancer Supportive Care Medicine Sales (K Units) Market Share by Types in 2017 1.2.3 Antiemetic Drugs 1.2.4 Erythropoietin-Stimulating Agents 1.2.5 Granulocyte-Stimulating Agents 1.2.6 Analgesics 1.2.7 Others 1.3 Asia-Pacific Cancer Supportive Care Medicine Market by Application/End Users 1.3.1 Asia-Pacific Cancer Supportive Care Medicine (K Units) and Market Share Comparison by Applications (2012-2023) 1.3.2 Chemotherapy-Induced Anemia 1.3.3 CINV 1.3.4 Bone Metastasis 1.3.5 Cancer Pain 1.3.6 Other 1.4 Asia-Pacific Cancer Supportive Care Medicine Market by Region 1.4.1 Asia-Pacific Cancer Supportive Care Medicine Revenue (Million USD) Comparison by Regions (2012-2023) 1.4.2 China Status and Prospect (2012-2023) 1.4.3 Japan Status and Prospect (2012-2023) 1.4.4 South Korea Status and Prospect (2012-2023) 1.4.5 Taiwan Status and Prospect (2012-2023) 1.4.6 India Status and Prospect (2012-2023) 1.4.7 Southeast Asia Status and Prospect (2012-2023) 1.4.8 Australia Status and Prospect (2012-2023) 1.5 Asia-Pacific Sales and Revenue ofSales and Revenue of Cancer Supportive Care Medicine (2012-2023) 1.5.1 Asia-Pacific Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (2012-2023) 1.5.2 Asia-Pacific Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (2012-2023) 2 Industrial Chain Analysis 2.1 Industry Chain Structure of Cancer Supportive Care Medicine 2.2 Raw Material Analysis of Cancer Supportive Care Medicine 2.1.1 Raw Material A Market Analysis 2.1.2 Raw Material B Market Analysis 2.1.3 Raw Material C Market Analysis 2.3 Labor Cost Analysis of K Units 2.4 Other Costs Analysis of Cancer Supportive Care Medicine 2.5 Manufacturing Cost Structure Analysis of Cancer Supportive Care Medicine 2.6 Manufacturing Process Analysis of Cancer Supportive Care Medicine 2.7 Raw Materials Sources of Cancer Supportive Care Medicine Major Manufacturers in 2018 2.8 Downstream Buyers 3 Asia-Pacific Cancer Supportive Care Medicine Players/Suppliers Profiles and Sales Data 3.1 Amgen 3.1.1 Company Basic Information, Manufacturing Base and Competitors 3.1.2 Cancer Supportive Care Medicine Product Category, Application and Specification 3.1.2.1 Product A 3.1.2.2 Product B 3.1.3 Amgen Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.1.4 Amgen Different Types of Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.1.5 Amgen Cancer Supportive Care Medicine Volume in Different Applications and Its Application Share 3.2 Helsinn Healthcare 3.2.1 Company Basic Information, Manufacturing Base and Competitors 3.2.2 Cancer Supportive Care Medicine Product Category, Application and Specification 3.2.2.1 Product A 3.2.2.2 Product B 3.2.3 Helsinn Healthcare Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.2.4 Helsinn Healthcare Different Types of Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.2.5 Helsinn Healthcare Cancer Supportive Care Medicine Volume in Different Applications and Its Application Share 3.3 Johnson &Johnson 3.3.1 Company Basic Information, Manufacturing Base and Competitors 3.3.2 Cancer Supportive Care Medicine Product Category, Application and Specification 3.3.2.1 Product A 3.3.2.2 Product B 3.3.3 Johnson &Johnson Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.3.4 Johnson &Johnson Different Types of Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.3.5 Johnson &Johnson Cancer Supportive Care Medicine Volume in Different Applications and Its Application Share 3.4 Merck 3.4.1 Company Basic Information, Manufacturing Base and Competitors 3.4.2 Cancer Supportive Care Medicine Product Category, Application and Specification 3.4.2.1 Product A 3.4.2.2 Product B 3.4.3 Merck Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.4.4 Merck Different Types of Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.4.5 Merck Cancer Supportive Care Medicine Volume in Different Applications and Its Application Share 3.5 F. Hoffmann-La Roche 3.5.1 Company Basic Information, Manufacturing Base and Competitors 3.5.2 Cancer Supportive Care Medicine Product Category, Application and Specification 3.5.2.1 Product A 3.5.2.2 Product B 3.5.3 F. Hoffmann-La Roche Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.5.4 F. Hoffmann-La Roche Different Types of Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.5.5 F. Hoffmann-La Roche Cancer Supportive Care Medicine Volume in Different Applications and Its Application Share 3.6 GlaxoSmithKline 3.6.1 Company Basic Information, Manufacturing Base and Competitors 3.6.2 Cancer Supportive Care Medicine Product Category, Application and Specification 3.6.2.1 Product A 3.6.2.2 Product B 3.6.3 GlaxoSmithKline Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.6.4 GlaxoSmithKline Different Types of Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.6.5 GlaxoSmithKline Cancer Supportive Care Medicine Volume in Different Applications and Its Application Share 3.7 Heron Therapeutics 3.7.1 Company Basic Information, Manufacturing Base and Competitors 3.7.2 Cancer Supportive Care Medicine Product Category, Application and Specification 3.7.2.1 Product A 3.7.2.2 Product B 3.7.3 Heron Therapeutics Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.7.4 Heron Therapeutics Different Types of Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.7.5 Heron Therapeutics Cancer Supportive Care Medicine Volume in Different Applications and Its Application Share 3.8 Kyowa Hakko Kirin 3.8.1 Company Basic Information, Manufacturing Base and Competitors 3.8.2 Cancer Supportive Care Medicine Product Category, Application and Specification 3.8.2.1 Product A 3.8.2.2 Product B 3.8.3 Kyowa Hakko Kirin Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.8.4 Kyowa Hakko Kirin Different Types of Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.8.5 Kyowa Hakko Kirin Cancer Supportive Care Medicine Volume in Different Applications and Its Application Share 3.9 Novartis 3.9.1 Company Basic Information, Manufacturing Base and Competitors 3.9.2 Cancer Supportive Care Medicine Product Category, Application and Specification 3.9.2.1 Product A 3.9.2.2 Product B 3.9.3 Novartis Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.9.4 Novartis Different Types of Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.9.5 Novartis Cancer Supportive Care Medicine Volume in Different Applications and Its Application Share 3.10 TESARO 3.10.1 Company Basic Information, Manufacturing Base and Competitors 3.10.2 Cancer Supportive Care Medicine Product Category, Application and Specification 3.10.2.1 Product A 3.10.2.2 Product B 3.10.3 TESARO Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.10.4 TESARO Different Types of Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.10.5 TESARO Cancer Supportive Care Medicine Volume in Different Applications and Its Application Share 3.11 Teva Pharmaceutical Industries 4 Asia-Pacific Cancer Supportive Care Medicine Competition by Players/Manufacturers, Region, Type and Application 4.1 Asia-Pacific Cancer Supportive Care Medicine Market Competition by Players/Manufacturers 4.1.1 Asia-Pacific Cancer Supportive Care Medicine Sales (K Units) and Market Share of Key Players/Suppliers (2012-2017) 4.1.2 Asia-Pacific Cancer Supportive Care Medicine Revenue (Million USD) and Share by Players/Suppliers (2012-2017) 4.2 Asia-Pacific Cancer Supportive Care Medicine Sales and Revenue by Type 4.2.1 Asia-Pacific Cancer Supportive Care Medicine Sales (K Units) and Market Share by Type (2012-2017) 4.2.2 Asia-Pacific Cancer Supportive Care Medicine Revenue (Million USD) and Market Share by Type (2012-2017) 4.3 Asia-Pacific Cancer Supportive Care Medicine Sales and Revenue by Application 4.3.1 Asia-Pacific Cancer Supportive Care Medicine Sales (K Units) and Market Share by Regions (2012-2017) 4.3.2 Asia-Pacific Cancer Supportive Care Medicine Revenue (Million USD) and Market Share (%) Regions (2012-2017) 4.4 Asia-Pacific Cancer Supportive Care Medicine Sales (K Units) by Application 5 China Cancer Supportive Care Medicine (Sales, Revenue and Price) 5.1 China Cancer Supportive Care Medicine Sales and Value (2012-2017) 5.1.1 China Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (2012-2017) 5.1.2 China Cancer Supportive Care Medicine Revenue and Growth Rate (2012-2017) 5.1.3 China Cancer Supportive Care Medicine Sales Price (USD/Unit) Trend (2012-2017) 5.2 China Cancer Supportive Care Medicine Sales (K Units) and Market Share by Type 5.3 China Cancer Supportive Care Medicine Sales (K Units) and Market Share by Application 6 Japan Cancer Supportive Care Medicine (Sales, Revenue and Price) 6.1 Japan Cancer Supportive Care Medicine Sales and Value (2012-2017) 6.1.1 Japan Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (2012-2017) 6.1.2 Japan Cancer Supportive Care Medicine Revenue and Growth Rate (2012-2017) 6.1.3 Japan Cancer Supportive Care Medicine Sales Price (USD/Unit) Trend (2012-2017) 6.2 Japan Cancer Supportive Care Medicine Sales (K Units) and Market Share by Type 6.3 Japan Cancer Supportive Care Medicine Sales (K Units) and Market Share by Application 7 South Korea Cancer Supportive Care Medicine (Sales, Revenue and Price) 7.1 South Korea Cancer Supportive Care Medicine Sales and Value (2012-2017) 7.1.1 South Korea Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (2012-2017) 7.1.2 South Korea Cancer Supportive Care Medicine Revenue and Growth Rate (2012-2017) 7.1.3 South Korea Cancer Supportive Care Medicine Sales Price (USD/Unit) Trend (2012-2017) 7.2 South Korea Cancer Supportive Care Medicine Sales (K Units) and Market Share by Type 7.3 South Korea Cancer Supportive Care Medicine Sales (K Units) and Market Share by Application 8 Taiwan Cancer Supportive Care Medicine (Sales, Revenue and Price) 8.1 Taiwan Cancer Supportive Care Medicine Sales and Value (2012-2017) 8.1.1 Taiwan Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (2012-2017) 8.1.2 Taiwan Cancer Supportive Care Medicine Revenue and Growth Rate (2012-2017) 8.1.3 Taiwan Cancer Supportive Care Medicine Sales Price (USD/Unit) Trend (2012-2017) 8.2 Taiwan Cancer Supportive Care Medicine Sales (K Units) and Market Share by Type 8.3 Taiwan Cancer Supportive Care Medicine Sales (K Units) and Market Share by Application 9 India Cancer Supportive Care Medicine (Sales, Revenue and Price) 9.1 India Cancer Supportive Care Medicine Sales and Value (2012-2017) 9.1.1 India Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (2012-2017) 9.1.2 India Cancer Supportive Care Medicine Revenue and Growth Rate (2012-2017) 9.1.3 India Cancer Supportive Care Medicine Sales Price (USD/Unit) Trend (2012-2017) 9.2 India Cancer Supportive Care Medicine Sales (K Units) and Market Share by Type 9.3 India Cancer Supportive Care Medicine Sales (K Units) and Market Share by Application 10 Southeast Asia Cancer Supportive Care Medicine (Sales, Revenue and Price) 10.1 Southeast Asia Cancer Supportive Care Medicine Sales and Value (2012-2017) 10.1.1 Southeast Asia Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (2012-2017) 10.1.2 Southeast Asia Cancer Supportive Care Medicine Revenue and Growth Rate (2012-2017) 10.1.3 Southeast Asia Cancer Supportive Care Medicine Sales Price (USD/Unit) Trend (2012-2017) 10.2 Southeast Asia Cancer Supportive Care Medicine Sales (K Units) and Market Share by Type 10.3 Southeast Asia Cancer Supportive Care Medicine Sales (K Units) and Market Share by Application 11 Australia Cancer Supportive Care Medicine (Sales, Revenue and Price) 11.1 Australia Cancer Supportive Care Medicine Sales and Value (2012-2017) 11.1.1 Australia Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (2012-2017) 11.1.2 Australia Cancer Supportive Care Medicine Revenue and Growth Rate (2012-2017) 11.1.3 Australia Cancer Supportive Care Medicine Sales Price (USD/Unit) Trend (2012-2017) 11.2 Australia Cancer Supportive Care Medicine Sales (K Units) and Market Share by Type 11.3 Australia Cancer Supportive Care Medicine Sales (K Units) and Market Share by Application 12 Marketing Strategy Analysis, Distributors/Traders 12.1 Direct Marketing 12.1.1 Direct Marketing 12.1.2 Indirect Marketing 12.1.3 Marketing Channel Development Trend 12.2 Market Positioning 12.2.1 Pricing Strategy 12.2.2 Brand Strategy 12.2.3 Target Client 12.3 Distributors/Traders List 13 Asia-Pacific Cancer Supportive Care Medicine Market Forecast (2018-2023) 13.1 Asia-Pacific Cancer Supportive Care Medicine Sales (K Units), Revenue and Price Forecast (2018-2023) 13.1.1 Asia-Pacific Cancer Supportive Care Medicine Sales (K Units) and Growth Rate Forecast (2018-2023) 13.1.2 Asia-Pacific Cancer Supportive Care Medicine Revenue and Growth Rate Forecast (2018-2023) 13.1.3 Asia-Pacific Cancer Supportive Care Medicine Price and Trend Forecast (2018-2023) 13.2 Asia-Pacific Cancer Supportive Care Medicine Sales (K Units), Revenue and Growth Rate Forecast by Region (2018-2023) 13.2.1 Asia-Pacific Cancer Supportive Care Medicine Sales (K Units) and Growth Rate Forecast by Region (2018-2023) 13.2.2 Asia-Pacific Cancer Supportive Care Medicine Revenue and Growth Rate Forecast by Region (2018-2023) 13.2.3 China Cancer Supportive Care Medicine Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.4 Japan Cancer Supportive Care Medicine Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.5 South Korea Cancer Supportive Care Medicine Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.6 Taiwan Cancer Supportive Care Medicine Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.7 South Korea Cancer Supportive Care Medicine Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.8 Southeast Asia Cancer Supportive Care Medicine Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.9 Australia Cancer Supportive Care Medicine Sales, Revenue and Growth Rate Forecast (2018-2023) 13.3 Asia-Pacific Cancer Supportive Care Medicine Sales, Revenue and Price Forecast by Type (2018-2023) 13.3.1 Asia-Pacific Cancer Supportive Care Medicine Sales Forecast by Type (2018-2023) 13.3.2 Asia-Pacific Cancer Supportive Care Medicine Revenue Forecast by Type (2018-2023) 13.3.3 Asia-Pacific Cancer Supportive Care Medicine Price Forecast by Type (2018-2023) 13.4 Asia-Pacific Cancer Supportive Care Medicine Sales Forecast by Application (2018-2023) 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology/Research Approach 15.1.1 Research Programs/Design 15.1.2 Market Size Estimation 15.1.3 Market Breakdown and Data Triangulation 15.2 Data Source 15.2.1 Secondary Sources 15.2.2 Primary Sources 15.3 Disclaimer

List of Tables and Figures Figure Asia-Pacific Market Size (Million USD) Comparison 2012-2023 Table Asia-Pacific Market Cancer Supportive Care Medicine Revenue (Million USD) Comparison by Regions 2012-2023 Table Asia-Pacific Cancer Supportive Care Medicine Sales (K Units) and Revenue (Million USD) Market Split by Product Type Table Asia-Pacific Cancer Supportive Care Medicine Sales (K Units) by Application (2016-2023) Figure Product Picture of Cancer Supportive Care Medicine Table Asia-Pacific Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (%) Comparison by Types (2012-2023) Figure Asia-Pacific Cancer Supportive Care Medicine Sales (K Units) Market Share by Types in 2017 Figure Antiemetic Drugs Picture Figure Erythropoietin-Stimulating Agents Picture Figure Granulocyte-Stimulating Agents Picture Table Asia-Pacific Cancer Supportive Care Medicine Sales (K Units) Comparison by Applications (2012-2023) Figure Asia-Pacific Sales Market Share of Cancer Supportive Care Medicine by Applications in 2017 Figure Chemotherapy-Induced Anemia Picture Figure CINV Picture Figure Bone Metastasis Picture Table Asia-Pacific Market Cancer Supportive Care Medicine Revenue (Million USD) Comparison by Regions 2012-2023 Figure China Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (2012-2023) Figure Japan Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (2012-2023) Figure South Korea Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (2012-2023) Figure Taiwan Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (2012-2023) Figure India Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (2012-2023) Figure Southeast Asia Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (2012-2023) Figure Australia Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (2012-2023) Figure Asia-Pacific Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (2012-2023) Figure Asia-Pacific Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (2012-2023) Figure New Project SWOT Analysis of Cancer Supportive Care Medicine Table Industry News List of Cancer Supportive Care Medicine Figure Industry Chain Structure of Cancer Supportive Care Medicine Table Raw Material Suppliers and Price Analysis Figure Global Raw Material A Price Trend (USD/MT) Figure Global Raw Material B Price Trend (USD/MT) Figure Global Raw Material C Price Trend (USD/MT) Table Manufacturing Cost Structure Analysis of Cancer Supportive Care Medicine in 2017 Figure Manufacturing Process Analysis of Cancer Supportive Care Medicine Table Raw Materials Sources of Cancer Supportive Care Medicine Major Manufacturers in 2017 Table Major Buyers of Cancer Supportive Care Medicine Table Amgen Basic Information List Table Amgen Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Amgen Cancer Supportive Care Medicine Sales Growth Rate (2012-2017) Figure Amgen Cancer Supportive Care Medicine Sales Asia-Pacific Market Share (%) (2012-2017) Figure Amgen Cancer Supportive Care Medicine Revenue Asia-Pacific Market Share (%) (2012-2017) Table Antiemetic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Erythropoietin-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Granulocyte-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Amgen Cancer Supportive Care Medicine Volume in Chemotherapy-Induced Anemia and Its Application Share Table Amgen Cancer Supportive Care Medicine Volume in CINV and Its Application Share Table Amgen Cancer Supportive Care Medicine Volume in Bone Metastasis and Its Application Share Table Helsinn Healthcare Basic Information List Table Helsinn Healthcare Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Helsinn Healthcare Cancer Supportive Care Medicine Sales Growth Rate (2012-2017) Figure Helsinn Healthcare Cancer Supportive Care Medicine Sales Asia-Pacific Market Share (%) (2012-2017) Figure Helsinn Healthcare Cancer Supportive Care Medicine Revenue Asia-Pacific Market Share (%) (2012-2017) Table Antiemetic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Erythropoietin-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Granulocyte-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Helsinn Healthcare Cancer Supportive Care Medicine Volume in Chemotherapy-Induced Anemia and Its Application Share Table Helsinn Healthcare Cancer Supportive Care Medicine Volume in CINV and Its Application Share Table Helsinn Healthcare Cancer Supportive Care Medicine Volume in Bone Metastasis and Its Application Share Table Johnson &Johnson Basic Information List Table Johnson &Johnson Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Johnson &Johnson Cancer Supportive Care Medicine Sales Growth Rate (2012-2017) Figure Johnson &Johnson Cancer Supportive Care Medicine Sales Asia-Pacific Market Share (%) (2012-2017) Figure Johnson &Johnson Cancer Supportive Care Medicine Revenue Asia-Pacific Market Share (%) (2012-2017) Table Antiemetic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Erythropoietin-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Granulocyte-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Johnson &Johnson Cancer Supportive Care Medicine Volume in Chemotherapy-Induced Anemia and Its Application Share Table Johnson &Johnson Cancer Supportive Care Medicine Volume in CINV and Its Application Share Table Johnson &Johnson Cancer Supportive Care Medicine Volume in Bone Metastasis and Its Application Share Table Merck Basic Information List Table Merck Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Merck Cancer Supportive Care Medicine Sales Growth Rate (2012-2017) Figure Merck Cancer Supportive Care Medicine Sales Asia-Pacific Market Share (%) (2012-2017) Figure Merck Cancer Supportive Care Medicine Revenue Asia-Pacific Market Share (%) (2012-2017) Table Antiemetic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Erythropoietin-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Granulocyte-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Merck Cancer Supportive Care Medicine Volume in Chemotherapy-Induced Anemia and Its Application Share Table Merck Cancer Supportive Care Medicine Volume in CINV and Its Application Share Table Merck Cancer Supportive Care Medicine Volume in Bone Metastasis and Its Application Share Table F. Hoffmann-La Roche Basic Information List Table F. Hoffmann-La Roche Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure F. Hoffmann-La Roche Cancer Supportive Care Medicine Sales Growth Rate (2012-2017) Figure F. Hoffmann-La Roche Cancer Supportive Care Medicine Sales Asia-Pacific Market Share (%) (2012-2017) Figure F. Hoffmann-La Roche Cancer Supportive Care Medicine Revenue Asia-Pacific Market Share (%) (2012-2017) Table Antiemetic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Erythropoietin-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Granulocyte-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table F. Hoffmann-La Roche Cancer Supportive Care Medicine Volume in Chemotherapy-Induced Anemia and Its Application Share Table F. Hoffmann-La Roche Cancer Supportive Care Medicine Volume in CINV and Its Application Share Table F. Hoffmann-La Roche Cancer Supportive Care Medicine Volume in Bone Metastasis and Its Application Share Table GlaxoSmithKline Basic Information List Table GlaxoSmithKline Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure GlaxoSmithKline Cancer Supportive Care Medicine Sales Growth Rate (2012-2017) Figure GlaxoSmithKline Cancer Supportive Care Medicine Sales Asia-Pacific Market Share (%) (2012-2017) Figure GlaxoSmithKline Cancer Supportive Care Medicine Revenue Asia-Pacific Market Share (%) (2012-2017) Table Antiemetic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Erythropoietin-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Granulocyte-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table GlaxoSmithKline Cancer Supportive Care Medicine Volume in Chemotherapy-Induced Anemia and Its Application Share Table GlaxoSmithKline Cancer Supportive Care Medicine Volume in CINV and Its Application Share Table GlaxoSmithKline Cancer Supportive Care Medicine Volume in Bone Metastasis and Its Application Share Table Heron Therapeutics Basic Information List Table Heron Therapeutics Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Heron Therapeutics Cancer Supportive Care Medicine Sales Growth Rate (2012-2017) Figure Heron Therapeutics Cancer Supportive Care Medicine Sales Asia-Pacific Market Share (%) (2012-2017) Figure Heron Therapeutics Cancer Supportive Care Medicine Revenue Asia-Pacific Market Share (%) (2012-2017) Table Antiemetic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Erythropoietin-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Granulocyte-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Heron Therapeutics Cancer Supportive Care Medicine Volume in Chemotherapy-Induced Anemia and Its Application Share Table Heron Therapeutics Cancer Supportive Care Medicine Volume in CINV and Its Application Share Table Heron Therapeutics Cancer Supportive Care Medicine Volume in Bone Metastasis and Its Application Share Table Kyowa Hakko Kirin Basic Information List Table Kyowa Hakko Kirin Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Kyowa Hakko Kirin Cancer Supportive Care Medicine Sales Growth Rate (2012-2017) Figure Kyowa Hakko Kirin Cancer Supportive Care Medicine Sales Asia-Pacific Market Share (%) (2012-2017) Figure Kyowa Hakko Kirin Cancer Supportive Care Medicine Revenue Asia-Pacific Market Share (%) (2012-2017) Table Antiemetic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Erythropoietin-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Granulocyte-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Kyowa Hakko Kirin Cancer Supportive Care Medicine Volume in Chemotherapy-Induced Anemia and Its Application Share Table Kyowa Hakko Kirin Cancer Supportive Care Medicine Volume in CINV and Its Application Share Table Kyowa Hakko Kirin Cancer Supportive Care Medicine Volume in Bone Metastasis and Its Application Share Table Novartis Basic Information List Table Novartis Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Novartis Cancer Supportive Care Medicine Sales Growth Rate (2012-2017) Figure Novartis Cancer Supportive Care Medicine Sales Asia-Pacific Market Share (%) (2012-2017) Figure Novartis Cancer Supportive Care Medicine Revenue Asia-Pacific Market Share (%) (2012-2017) Table Antiemetic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Erythropoietin-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Granulocyte-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Novartis Cancer Supportive Care Medicine Volume in Chemotherapy-Induced Anemia and Its Application Share Table Novartis Cancer Supportive Care Medicine Volume in CINV and Its Application Share Table Novartis Cancer Supportive Care Medicine Volume in Bone Metastasis and Its Application Share Table Company TESARO Basic Information List Table Company TESARO Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Company TESARO Cancer Supportive Care Medicine Sales Growth Rate (2012-2017) Figure Company TESARO Cancer Supportive Care Medicine Sales Asia-Pacific Market Share (%) (2012-2017) Figure Company TESARO Cancer Supportive Care Medicine Revenue Asia-Pacific Market Share (%) (2012-2017) Table Antiemetic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Erythropoietin-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Granulocyte-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Company TESARO Cancer Supportive Care Medicine Volume in Chemotherapy-Induced Anemia and Its Application Share Table Company TESARO Cancer Supportive Care Medicine Volume in CINV and Its Application Share Table Company TESARO Cancer Supportive Care Medicine Volume in Bone Metastasis and Its Application Share Table Asia-Pacific Cancer Supportive Care Medicine Sales (K Units) by Players/Manufacturers (2012-2017) Table Asia-Pacific Cancer Supportive Care Medicine Sales Share (%) by Players/Manufacturers (2012-2017) Figure 2016 Asia-Pacific Cancer Supportive Care Medicine Sales Market Share (%) by Players/Manufacturers Figure 2017 Asia-Pacific Cancer Supportive Care Medicine Sales Share by Players/Manufacturers Table Asia-Pacific Cancer Supportive Care Medicine Revenue (Million USD) by Players/Manufacturers (2012-2017) Table Asia-Pacific Cancer Supportive Care Medicine Revenue Market Share (%) Players/Manufacturers (2012-2017) Figure 2016 Asia-Pacific Cancer Supportive Care Medicine Revenue Market Share (%) Players Figure 2017 Asia-Pacific Cancer Supportive Care Medicine Revenue Market Share (%) Players Table Asia-Pacific Cancer Supportive Care Medicine Sales (K Units) and Market Share (%) by Type (2012-2017) Table Asia-Pacific Cancer Supportive Care Medicine Sales Share by Type (2012-2017) Figure Sales Market Share of Cancer Supportive Care Medicine by Type (2012-2017) Figure Asia-Pacific Cancer Supportive Care Medicine Sales Growth Rate (%) by Type (2012-2017) Table Asia-Pacific Cancer Supportive Care Medicine Revenue (Million USD) and Market Share (%) Type (2012-2017) Table Asia-Pacific Cancer Supportive Care Medicine Revenue Market Share (%) Type (2012-2017) Figure Revenue Market Share of Cancer Supportive Care Medicine by Type (2012-2017) Figure Asia-Pacific Cancer Supportive Care Medicine Revenue Growth Rate by Type (2012-2017) Table Asia-Pacific Cancer Supportive Care Medicine Sales (K Units) and Market Share by Regions (2012-2017) Table Asia-Pacific Cancer Supportive Care Medicine Sales Share by Regions (2012-2017) Figure Sales Market Share of Cancer Supportive Care Medicine by Regions (2012-2017) Figure Asia-Pacific Cancer Supportive Care Medicine Sales Market Share by Regions in 2017 Table Asia-Pacific Cancer Supportive Care Medicine Revenue (Million USD) and Market Share by Regions (2012-2017) Table Asia-Pacific Cancer Supportive Care Medicine Revenue Share (%) by Regions (2012-2017) Figure Revenue Market Share of Cancer Supportive Care Medicine by Regions (2012-2017) Figure Asia-Pacific Cancer Supportive Care Medicine Revenue Market Share by Regions in 2017 Table Asia-Pacific Cancer Supportive Care Medicine Sales (K Units) and Market Share by Application (2012-2017) Table Asia-Pacific Cancer Supportive Care Medicine Sales Share (%) by Application (2012-2017) Figure Asia-Pacific Cancer Supportive Care Medicine Sales Market Share by Application (2012-2017) Figure Asia-Pacific Cancer Supportive Care Medicine Sales Market Share by Application (2012-2017) Figure China Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (%) (2012-2017) Figure China Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure China Cancer Supportive Care Medicine Sales Price (USD/Unit) Trend (2012-2017) Table China Cancer Supportive Care Medicine Sales (K Units) by Type (2012-2017) Table China Cancer Supportive Care Medicine Sales (K Units) Market Share by Type (2012-2017) Figure China Cancer Supportive Care Medicine Sales (K Units) Market Share by Type in 2017 Table China Cancer Supportive Care Medicine Sales (K Units) by Applications (2012-2017) Table China Cancer Supportive Care Medicine Sales (K Units) Market Share by Applications (2012-2017) Figure China Cancer Supportive Care Medicine Sales (K Units) Market Share by Applications in 2017 Figure Japan Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (2012-2017) Figure Japan Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Japan Cancer Supportive Care Medicine Sales Price (USD/Unit) Trend (2012-2017) Table Japan Cancer Supportive Care Medicine Sales (K Units) by Type (2012-2017) Table Japan Cancer Supportive Care Medicine Sales (K Units) Market Share by Type (2012-2017) Figure Japan Cancer Supportive Care Medicine Sales (K Units) Market Share by Type in 2017 Table Japan Cancer Supportive Care Medicine Sales (K Units) by Applications (2012-2017) Table Japan Cancer Supportive Care Medicine Sales (K Units) Market Share by Applications (2012-2017) Figure Japan Cancer Supportive Care Medicine Sales (K Units) Market Share by Applications in 2017 Figure South Korea Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (2012-2017) Figure South Korea Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure South Korea Cancer Supportive Care Medicine Sales Price (USD/Unit) Trend (2012-2017) Table South Korea Cancer Supportive Care Medicine Sales (K Units) by Type (2012-2017) Table South Korea Cancer Supportive Care Medicine Sales (K Units) Market Share by Type (2012-2017) Figure South Korea Cancer Supportive Care Medicine Sales (K Units) Market Share by Type in 2017 Table South Korea Cancer Supportive Care Medicine Sales (K Units) by Applications (2012-2017) Table South Korea Cancer Supportive Care Medicine Sales (K Units) Market Share by Applications (2012-2017) Figure South Korea Cancer Supportive Care Medicine Sales (K Units) Market Share by Applications in 2017 Figure Taiwan Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (2012-2017) Figure Taiwan Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Taiwan Cancer Supportive Care Medicine Sales Price (USD/Unit) Trend (2012-2017) Table Taiwan Cancer Supportive Care Medicine Sales (K Units) by Type (2012-2017) Table Taiwan Cancer Supportive Care Medicine Sales (K Units) Market Share by Type (2012-2017) Figure Taiwan Cancer Supportive Care Medicine Sales (K Units) Market Share by Type in 2017 Table Taiwan Cancer Supportive Care Medicine Sales (K Units) by Applications (2012-2017) Table Taiwan Cancer Supportive Care Medicine Sales (K Units) Market Share by Applications (2012-2017) Figure Taiwan Cancer Supportive Care Medicine Sales (K Units) Market Share by Applications in 2017 Figure Southeast Asia Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (2012-2017) Figure Southeast Asia Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Southeast Asia Cancer Supportive Care Medicine Sales Price (USD/Unit) Trend (2012-2017) Table Southeast Asia Cancer Supportive Care Medicine Sales (K Units) by Type (2012-2017) Table Southeast Asia Cancer Supportive Care Medicine Sales (K Units) Market Share by Type (2012-2017) Figure Southeast Asia Cancer Supportive Care Medicine Sales (K Units) Market Share by Type in 2017 Table Southeast Asia Cancer Supportive Care Medicine Sales (K Units) by Applications (2012-2017) Table Southeast Asia Cancer Supportive Care Medicine Sales (K Units) Market Share by Applications (2012-2017) Figure Southeast Asia Cancer Supportive Care Medicine Sales (K Units) Market Share by Applications in 2017 Figure India Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (2012-2017) Figure India Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure India Cancer Supportive Care Medicine Sales Price (USD/Unit) Trend (2012-2017) Table India Cancer Supportive Care Medicine Sales (K Units) by Type (2012-2017) Table India Cancer Supportive Care Medicine Sales (K Units) Market Share by Type (2012-2017) Figure India Cancer Supportive Care Medicine Sales (K Units) Market Share by Type in 2017 Table India Cancer Supportive Care Medicine Sales (K Units) by Applications (2012-2017) Table India Cancer Supportive Care Medicine Sales (K Units) Market Share by Applications (2012-2017) Figure India Cancer Supportive Care Medicine Sales (K Units) Market Share by Applications in 2017 Figure Australia Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (2012-2017) Figure Australia Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Australia Cancer Supportive Care Medicine Sales Price (USD/Unit) Trend (2012-2017) Table Australia Cancer Supportive Care Medicine Sales (K Units) by Type (2012-2017) Table Australia Cancer Supportive Care Medicine Sales (K Units) Market Share by Type (2012-2017) Figure Australia Cancer Supportive Care Medicine Sales (K Units) Market Share by Type in 2017 Table Australia Cancer Supportive Care Medicine Sales (K Units) by Applications (2012-2017) Table Australia Cancer Supportive Care Medicine Sales (K Units) Market Share by Applications (2012-2017) Figure Australia Cancer Supportive Care Medicine Sales (K Units) Market Share by Applications in 2017 Table Distributors/Traders List Figure Asia-Pacific Cancer Supportive Care Medicine Sales (K Units) and Growth Rate Forecast (2018-2023) Figure Asia-Pacific Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Asia-Pacific Cancer Supportive Care Medicine Price and Trend Forecast (2018-2023) Table Asia-Pacific Cancer Supportive Care Medicine Sales (K Units) Forecast by Regions (2018-2023) Figure Asia-Pacific Cancer Supportive Care Medicine Sales (K Units) Market Share Forecast by Regions (2018-2023) Figure Asia-Pacific Cancer Supportive Care Medicine Sales (K Units) Market Share Forecast by Regions in 2023 Table Asia-Pacific Cancer Supportive Care Medicine Revenue (Million USD) Forecast by Regions (2018-2023) Figure Asia-Pacific Cancer Supportive Care Medicine Revenue Market Share Forecast by Regions (2018-2023) Figure Asia-Pacific Cancer Supportive Care Medicine Revenue Market Share Forecast by Regions in 2023 Figure China Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure China Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure South Korea Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure South Korea Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Japan Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Japan Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Taiwan Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Taiwan Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure India Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure India Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Southeast Asia Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Southeast Asia Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Australia Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Australia Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Table Asia-Pacific Cancer Supportive Care Medicine Sales (K Units) Forecast by Type (2018-2023) Figure Asia-Pacific Cancer Supportive Care Medicine Sales Market Share Forecast by Type (2018-2023) Table Asia-Pacific Cancer Supportive Care Medicine Revenue (Million USD) Forecast by Type (2018-2023) Figure Asia-Pacific Cancer Supportive Care Medicine Revenue Market Share Forecast by Type (2018-2023) Table Asia-Pacific Cancer Supportive Care Medicine Price (USD/Unit) Forecast by Type (2018-2023) Table Asia-Pacific Cancer Supportive Care Medicine Sales (K Units) Forecast by Application (2018-2023) Figure Asia-Pacific Cancer Supportive Care Medicine Sales Market Share Forecast by Application (2018-2023) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Amgen Helsinn Healthcare Johnson &Johnson Merck F. Hoffmann-La Roche GlaxoSmithKline Heron Therapeutics Kyowa Hakko Kirin Novartis TESARO Teva Pharmaceutical Industries